Propanc Biopharma PPCB
NASDAQ PPCB
$1.08 -0.02 (-1.82%)
At close: Aug 21, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Return on Invested Capital (QoQ) (2012 - 2024)

Propanc Biopharma (PPCB) Return on Invested Capital (QoQ) (2012 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Propanc Biopharma 587,855.41 587,855.41 -

Historic Data

Download Data
DateValue
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Jun 30, 2018 0.00
Mar 31, 2018 0.00
Jun 30, 2017 11.00
Mar 31, 2017 -8.00
Dec 31, 2016 -2.00
Sep 30, 2016 -1.00